Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12077587 Anti-CD8 antibodies and uses thereof

Patent 12077587 was granted and assigned to Regeneron Pharmaceuticals on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Date Filed
October 26, 2022
0
Date of Patent
September 3, 2024
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Application Number
18049972
0
Patent Citations
‌
US Patent 9546206 High affinity PD-1 agents and methods of use
0
‌
US Patent 7087411 Fusion protein capable of binding VEGF
0
‌
US Patent 8771966 Immuno-PET imaging of antibodies and immunoconjugates and uses therefor
0
‌
US Patent 9429584 Antibody against insoluble fibrin
0
‌
US Patent 9475874 Nucleic acids encoding human antibodies to sialyl-lewis
0
‌
US Patent 10730944 Anti-CD8 antibodies and uses thereof
0
Patent Inventor Names
William Olson
0
Jason T. Giurleo
0
Richard Tavare
0
Gavin Thurston
0
Dangshe Ma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12077587
0
Patent Primary Examiner
‌
Karl J Puttlitz
0

Find more entities like US Patent 12077587 Anti-CD8 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo